These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39382929)
1. Clinical Value of Routine Biomarkers for Colorectal Patients: a Retrospective Study. Jiang C; Huang JH; Cong H Clin Lab; 2024 Oct; 70(10):. PubMed ID: 39382929 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic performances of methylated septin9 gene, CEA, CA19-9 and platelet-to-lymphocyte ratio in colorectal cancer. Sun Q; Long L BMC Cancer; 2024 Jul; 24(1):906. PubMed ID: 39068425 [TBL] [Abstract][Full Text] [Related]
3. Exploration of the application potential of serum multi-biomarker model in colorectal cancer screening. Xu R; Shen J; Song Y; Lu J; Liu Y; Cao Y; Wang Z; Zhang J Sci Rep; 2024 May; 14(1):10127. PubMed ID: 38698075 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma. Zhang SY; Lin M; Zhang HB Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695 [TBL] [Abstract][Full Text] [Related]
5. Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer. Zhong W; Yu Z; Zhan J; Yu T; Lin Y; Xia ZS; Yuan YH; Chen QK Pathol Oncol Res; 2015 Jan; 21(1):83-95. PubMed ID: 24875250 [TBL] [Abstract][Full Text] [Related]
6. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer]. Qian X; Wang H; Ren Z; Jin F; Pan SY Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062 [No Abstract] [Full Text] [Related]
7. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer. Wang YR; Yan JX; Wang LN J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941 [TBL] [Abstract][Full Text] [Related]
8. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC. Peng HX; Yang L; He BS; Pan YQ; Ying HQ; Sun HL; Lin K; Hu XX; Xu T; Wang SK J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27686880 [TBL] [Abstract][Full Text] [Related]
9. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer. Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169 [TBL] [Abstract][Full Text] [Related]
10. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer. Knychalski B; Lukieńczuk T Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741 [TBL] [Abstract][Full Text] [Related]
11. Clinical diagnostic value of methylated SEPT9 combined with NLR, PLR and LMR in colorectal cancer. Huang M; Deng S; Li M; Yang Z; Guo J; Deng Y; Chen D; Yan B BMC Gastroenterol; 2024 Jul; 24(1):240. PubMed ID: 39075402 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer]. Huang L; Fang J; Wu J; Zhou X; Wei H Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1421-1426. PubMed ID: 30588596 [TBL] [Abstract][Full Text] [Related]
13. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Jiang ZF; Wang M; Xu JL Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745 [TBL] [Abstract][Full Text] [Related]
14. The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer. Halilovic E; Rasic I; Sofic A; Mujic A; Rovcanin A; Hodzic E; Kulovic E Med Arch; 2020 Oct; 74(5):346-349. PubMed ID: 33424087 [TBL] [Abstract][Full Text] [Related]
15. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis. Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902 [TBL] [Abstract][Full Text] [Related]
17. The role of carcinoembryonic antigen as an assessment tool for predicting disease severity among patients with colorectal cancer in resource-poor setting of Kwazulu-Natal, South Africa. Naicker YD; Moolla Z; Madiba T Pan Afr Med J; 2021; 39():185. PubMed ID: 34584610 [TBL] [Abstract][Full Text] [Related]
18. The combined detection of hematological indicators is used for the differential diagnosis of colorectal cancer and benign-colorectal lesions. Zhang X; Wu YY; Qin YY; Lin FQ Cancer Biomark; 2024; 39(3):223-230. PubMed ID: 38217586 [TBL] [Abstract][Full Text] [Related]
19. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients. Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815 [TBL] [Abstract][Full Text] [Related]
20. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer. Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]